Literature DB >> 33417809

Engineering Nanoparticles for Optimized Photodynamic Therapy.

Xinxin Dai1, Ting Du2, Kai Han1,3.   

Abstract

Photodynamic therapy as a local therapeutic method shows great biocompatibility in tumor therapy. However, the poor accumulation of photosensitizer in tumors restricted the therapeutic efficacy. Different from traditional chemotherapeutic drugs, some additional issues will further decrease the photodynamic therapeutic efficacy including the oxygen concentration and the short half life of reactive oxygen species. Nanoparticles as drug carriers are currently under rapid development for tumor therapy, especially in photodynamic therapy. This review mainly focuses on the design of nanoparticles for photodynamic therapy, with special emphasis on optimizing the therapeutic efficacy via the tumor tissue/organelles target, oxygen supply, and combination therapy.

Entities:  

Keywords:  combination therapy; nanoparticles; photodynamic therapy; tumor target

Year:  2019        PMID: 33417809     DOI: 10.1021/acsbiomaterials.9b01251

Source DB:  PubMed          Journal:  ACS Biomater Sci Eng        ISSN: 2373-9878


  4 in total

1.  Dimensional Reduction Enhances Photodynamic Therapy of Metal-Organic Nanophotosensitizers.

Authors:  Taokun Luo; Yingjie Fan; Jianming Mao; Eric Yuan; Eric You; Ziwan Xu; Wenbin Lin
Journal:  J Am Chem Soc       Date:  2022-03-17       Impact factor: 16.383

2.  Photoinduced free radical-releasing systems and their anticancer properties.

Authors:  Jieyu Yan; Haiwang Lai; Boning Zeng; Liqing Wang; Feiyue Xing; Pu Xiao
Journal:  Photochem Photobiol Sci       Date:  2022-05-13       Impact factor: 4.328

3.  Influence of Parameters on Photodynamic Therapy of Au@TiO2-HMME Core-Shell Nanostructures.

Authors:  Ping Wang; Luwei Zhang; Zhenxi Zhang; Sijia Wang; Cuiping Yao
Journal:  Nanomaterials (Basel)       Date:  2022-04-15       Impact factor: 5.719

4.  A Novel NIR Fluorescent Nanoprobe Targeting HER2-Positive Breast Cancer: Tra-TTR-A.

Authors:  Meijuan Chen; Zhousheng Lin; Guangyu Yao; Xi Hong; Xiaolei Xue; Lujia Chen
Journal:  Bioinorg Chem Appl       Date:  2021-12-30       Impact factor: 7.778

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.